Jacobs v. Niagen Bioscience, Inc.

What this case is about

Consumers are suing Niagen Bioscience, a company that sells nicotinamide riboside (NR) supplements, alleging that the company made false and misleading claims about the health benefits of its products. The plaintiffs contend that the company advertised its supplements as capable of delivering specific wellness or anti-aging benefits that are not supported by credible scientific evidence. Buyers claim they paid a premium price for the products based on these deceptive marketing claims and would not have purchased them, or would have paid less, had they known the advertised benefits were overstated or unproven. The proposed class is expected to include consumers across the United States who purchased Niagen Bioscience supplements during a defined period.

What happens next

The case is in its earliest stage. The defendant has not yet responded. Class certification — the court's decision on whether the case can proceed as a class action — typically takes 12 to 24 months after filing. See our FAQ for how class actions work and what it means to be a class member.

Source: CourtListener docket entry. This summary was generated automatically from the public docket and has not been reviewed by an attorney. It may contain errors and may not reflect subsequent filings. Published by Access Law Group; responsible attorney Bogdan Enica, Esq..